With over a decade of experience in healthcare consulting and investment, Xi has led strategic growth and market access initiatives for healthcare companies, startups, and private equity firms. Her expertise encompasses management consulting, commercial evaluations, and market access strategy.

Xi has held positions at Fosun Pharma, Boston Consulting Group, AstraZeneca, and Ernst & Young. This diverse background provides comprehensive understanding of both the strategic and operational challenges that healthcare companies face as they scale.

Her ability to assess market opportunities, develop commercialization strategies, and navigate complex healthcare systems helps portfolio companies translate technological innovation into sustainable business models.